Thomas Gerner Jacobsen

Thomas Gerner Jacobsen is a seasoned pharmaceutical executive with extensive experience in business development and management. As a co-founder and Chief Business Development Officer at Hyloris Pharmaceuticals since June 2012, Thomas has also held significant roles such as Owner at BDgenerics and Co-founder and Board Member at ALTER PHARMA from August 2010 to June 2021. Previously, leadership at Neogen included responsibilities as co-founder and Vice President of Business Development, focusing on non-US markets. Thomas's career began in various roles at Paranova-Gruppen A/S and culminated in a Market Manager position at Alternova A/S. Educational qualifications include an HD(U) from Copenhagen Business School and a Cand. pharm from Danmarks Farmaceutiske Universitet.